Bill ® Glucosamine Sulfate 2KCL 500mg Caplets
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Macrogol 3350, Hypromellose, Talc, Dioxyde de titanium, Cellulose, microcristalline, Poly(alcool vinylique)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Caplet | 3 Tous les jours |
Uses authorised in Canada
Glucosamine helps to relieve joint pain associated with osteoarthritis, protects against the deterioration of cartilage and it is a factor in the building of healthy cartilage.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms worsen. Do not use if security seal is missing or broken.
Product record
- Other names
- Bill Glucosamine Sulfate 500mg Tablets
- Licence holder
- Bill Beauty & Health Products Ltd.
- NPN or DIN-HM
- 80002337
- Status
- Active licence
- Licence date
- 6 November 2006
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80002337
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.